메뉴 건너뛰기




Volumn 19, Issue 8 SUPPL, 2013, Pages

Current state of type 2 diabetes management

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CANAGLIFLOZIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; INSULIN DERIVATIVE; LIRAGLUTIDE; SITAGLIPTIN; SODIUM GLUCOSE COTRANSPORTER 2; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; A1CF PROTEIN, HUMAN; INSULIN; RNA BINDING PROTEIN;

EID: 84899057527     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)

References (29)
  • 1
    • 0031851293 scopus 로고    scopus 로고
    • Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
    • DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-D
    • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553. (Pubitemid 28319935)
    • (1998) Diabetic Medicine , vol.15 , Issue.7 , pp. 539-553
    • Alberti, K.G.M.M.1    Zimmet, P.Z.2
  • 2
    • 75149130955 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
    • (2010) Diabetes Care , vol.33 , Issue.SUPPL. 1
  • 4
    • 84871995815 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2013
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
    • (2013) Diabetes Care , vol.36 , Issue.SUPPL. 1
  • 5
    • 64349083605 scopus 로고    scopus 로고
    • Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006
    • Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-453.
    • (2009) Am J Med , vol.122 , Issue.5 , pp. 443-453
    • Cheung, B.M.1    Ong, K.L.2    Cherny, S.S.3    Sham, P.C.4    Tso, A.W.5    Lam, K.S.6
  • 6
    • 84864870066 scopus 로고    scopus 로고
    • Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes - National Health and Nutrition Examination Survey, United States, 2007-2010
    • Centers for Disease Control and Prevention (CDC)
    • Ali MK, McKeever Bullard K, Imperatore G, Barker L, Gregg EW; Centers for Disease Control and Prevention (CDC). Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes - National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Morb Mortal Wkly Rep. 2012;61(suppl):32-37.
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , Issue.SUPPL. , pp. 32-37
    • Ali, M.K.1    McKeever Bullard, K.2    Imperatore, G.3    Barker, L.4    Gregg, E.W.5
  • 7
    • 13644263258 scopus 로고    scopus 로고
    • Oral antidiabetic agents: Current role in type 2 diabetes mellitus
    • DOI 10.2165/00003495-200565030-00005
    • Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385-411. (Pubitemid 40227460)
    • (2005) Drugs , vol.65 , Issue.3 , pp. 385-411
    • Krentz, A.J.1    Bailey, C.J.2
  • 8
    • 22044439398 scopus 로고    scopus 로고
    • Oral agents for type 2 diabetes: An update
    • DOI 10.2337/diaclin.23.2.64
    • Kimmel B, Inzucchi SE. Oral agents for type 2 diabetes: an update. Clinical Diabetes. 2005;23(2):64-76. (Pubitemid 40965047)
    • (2005) Clinical Diabetes , vol.23 , Issue.2 , pp. 64-76
    • Kimmel, B.1    Inzucchi, S.E.2
  • 9
    • 33845472504 scopus 로고    scopus 로고
    • Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    • DOI 10.2337/dc06-0703
    • Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE; Sitagliptin Study 021 Group. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29(12):2632-2637. (Pubitemid 44912190)
    • (2006) Diabetes Care , vol.29 , Issue.12 , pp. 2632-2637
    • Aschner, P.1    Kipnes, M.S.2    Lunceford, J.K.3    Sanchez, M.4    Mickel, C.5    Williams-Herman, D.E.6
  • 10
    • 33845476757 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    • DOI 10.2337/dc06-0706
    • Charbonnel B, Karasik A, Liu J, Wu M, Meininger G; Sitagliptin Study 020 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care. 2006;29(12):2638-2643. (Pubitemid 44912191)
    • (2006) Diabetes Care , vol.29 , Issue.12 , pp. 2638-2643
    • Charbonnel, B.1    Karasik, A.2    Liu, J.3    Wu, M.4    Meininger, G.5
  • 11
    • 0033578476 scopus 로고    scopus 로고
    • Pharmacologic therapy for type 2 diabetes mellitus
    • DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131(4):281-303. (Pubitemid 29383658)
    • (1999) Annals of Internal Medicine , vol.131 , Issue.4 , pp. 281-303
    • DeFronzo, R.A.1
  • 12
    • 84878784631 scopus 로고    scopus 로고
    • Lincolnshire, IL: Takeda Pharmaceuticals America, Inc
    • Actos [package insert]. Lincolnshire, IL: Takeda Pharmaceuticals America, Inc; 2011.
    • (2011) Actos [Package Insert]
  • 14
    • 77956855349 scopus 로고    scopus 로고
    • Princeton, NJ: Bristol-Myers Squibb
    • Glucophage [package insert]. Princeton, NJ: Bristol-Myers Squibb; 2008.
    • (2008) Glucophage [Package Insert]
  • 16
    • 79951704452 scopus 로고    scopus 로고
    • Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: A retrospective observational pharmacy claims analysis
    • Garg R, Chen W, Pendergrass M. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care. 2010;33(11): 2349-2354.
    • (2010) Diabetes Care , vol.33 , Issue.11 , pp. 2349-2354
    • Garg, R.1    Chen, W.2    Pendergrass, M.3
  • 17
    • 84877757399 scopus 로고    scopus 로고
    • The place of GLP-1-based therapy in diabetes management: Differences between DPP-4 inhibitors and GLP-1 receptor agonists
    • Eckerle Mize DL, Salehi M. The place of GLP-1-based therapy in diabetes management: differences between DPP-4 inhibitors and GLP-1 receptor agonists. Curr Diab Rep. 2013;13(3):307-318.
    • (2013) Curr Diab Rep , vol.13 , Issue.3 , pp. 307-318
    • Eckerle Mize, D.L.1    Salehi, M.2
  • 18
    • 84858225542 scopus 로고    scopus 로고
    • Novel pharmacological approaches to the treatment of type 2 diabetes
    • Verspohl EJ. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev. 2012;64(2):188-237.
    • (2012) Pharmacol Rev , vol.64 , Issue.2 , pp. 188-237
    • Verspohl, E.J.1
  • 19
    • 1242272759 scopus 로고    scopus 로고
    • The sodium/glucose cotransport family SLC5
    • DOI 10.1007/s00424-003-1063-6, The ABCs of Solute Carriers: Physiological, Pathological and Therapeutic Implications of Human Membrane Transport Proteins
    • Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510-518. (Pubitemid 38241437)
    • (2004) Pflugers Archiv European Journal of Physiology , vol.447 , Issue.5 , pp. 510-518
    • Wright, E.M.1    Turk, E.2
  • 20
    • 0029938022 scopus 로고    scopus 로고
    • Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes
    • Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol. 1996;270(4, pt 1):G541-G553.
    • (1996) Am J Physiol , vol.270 , Issue.4 PART 1
    • Thorens, B.1
  • 21
    • 64749099761 scopus 로고    scopus 로고
    • Glucose control by the kidney: An emerging target in diabetes
    • Marsenic O. Glucose control by the kidney: an emerging target in diabetes. Am J Kidney Dis. 2009;53:875-883.
    • (2009) Am J Kidney Dis , vol.53 , pp. 875-883
    • Marsenic, O.1
  • 22
    • 0001524988 scopus 로고
    • Glucose transport in the renal proximal tubule
    • Windhager EE, ed. New York, NY: Oxford University Press
    • Silverman M, Turner RJ. Glucose transport in the renal proximal tubule. In: Windhager EE, ed. Handbook of Physiology: Renal Physiology. New York, NY: Oxford University Press; 1992:2017-2038.
    • (1992) Handbook of Physiology: Renal Physiology , pp. 2017-2038
    • Silverman, M.1    Turner, R.J.2
  • 23
    • 84874291673 scopus 로고    scopus 로고
    • Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
    • Stenlöf K, Cefalu WT, Kim KA, et al. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab. 2013;15(4):372-382.
    • (2013) Diabetes Obes Metab , vol.15 , Issue.4 , pp. 372-382
    • Stenlöf, K.1    Cefalu, W.T.2    Kim, K.A.3
  • 24
    • 67049132386 scopus 로고    scopus 로고
    • Clinical application of incretin-based therapy: Therapeutic potential, patient selection and clinical use
    • Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med. 2009;122(6 suppl):S37-S50.
    • (2009) Am J Med , vol.122 , Issue.6 SUPPL.
    • Kendall, D.M.1    Cuddihy, R.M.2    Bergenstal, R.M.3
  • 25
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    • American Diabetes Association; European Association for the Study of Diabetes
    • Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
    • (2012) Diabetes Care , vol.35 , Issue.6 , pp. 1364-1379
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 26
    • 79960952161 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: Executive summary
    • AACE Task Force for Developing a Diabetes Comprehensive Care Plan
    • Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing a Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011;17(2):287-302.
    • (2011) Endocr Pract , vol.17 , Issue.2 , pp. 287-302
    • Handelsman, Y.1    Mechanick, J.I.2    Blonde, L.3
  • 27
    • 84856740961 scopus 로고    scopus 로고
    • Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians
    • Clinical Guidelines Committee of the American College of Physicians
    • Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156(3):218-231.
    • (2012) Ann Intern Med , vol.156 , Issue.3 , pp. 218-231
    • Qaseem, A.1    Humphrey, L.L.2    Sweet, D.E.3    Starkey, M.4    Shekelle, P.5
  • 28
    • 11844250564 scopus 로고    scopus 로고
    • Insulin analogues
    • DOI 10.1056/NEJMra040832
    • Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):174-183. (Pubitemid 40096614)
    • (2005) New England Journal of Medicine , vol.352 , Issue.2 , pp. 174-183
    • Hirsch, I.B.1
  • 29
    • 27844545747 scopus 로고    scopus 로고
    • Insulin analogues in children and teens with type 1 diabetes: Advantages and caveats
    • DOI 10.1016/j.pcl.2005.07.010, PII S0031395505001331, Diabetes Mellitus in Children
    • Rachmiel M, Perlman K, Daneman D. Insulin analogues in children and teens with type 1 diabetes: advantages and caveats. Pediatr Clin North Am. 2005;52(6):1651-1675. (Pubitemid 41654733)
    • (2005) Pediatric Clinics of North America , vol.52 , Issue.6 , pp. 1651-1675
    • Rachmiel, M.1    Perlman, K.2    Daneman, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.